News

WPRI 122y
Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC - WPRI.com
OSLO, Norway, Feb. 20, 2023 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the presentation of clinical data from the Veterans Affairs (VA) BRAVO study at the ASCO ...
Oklahoma's News2y
Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC - KFOR.com
OSLO, Norway, Feb. 20, 2023 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the presentation of clinical data from the Veterans Affairs (VA) BRAVO study at the ASCO ...
WIVB-TV2y
Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC - WIVB News 4
OSLO, Norway, Feb. 20, 2023 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the presentation of clinical data from the Veterans Affairs (VA) BRAVO study at the ASCO ...
WSPA2y
Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC - WSPA 7News
OSLO, Norway, Feb. 20, 2023 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the presentation of clinical data from the Veterans Affairs (VA) BRAVO study at the ASCO ...
WTEN2y
Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC - NEWS10 ABC
OSLO, Norway, Feb. 20, 2023 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the presentation of clinical data from the Veterans Affairs (VA) BRAVO study at the ASCO ...